ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05145	Toxoplasmosis	3/8	126/7206	0.000274183276646
ko05144	Malaria	2/8	45/7206	0.00104259480253
ko05321	Inflammatory bowel disease (IBD)	2/8	56/7206	0.00161191984283
ko05140	Leishmaniasis	2/8	75/7206	0.0028740408145
ko04620	Toll-like receptor signaling pathway	2/8	100/7206	0.00505577353346
ko05162	Measles	2/8	120/7206	0.00721172313193
ko04621	NOD-like receptor signaling pathway	2/8	157/7206	0.0121162989521
ko05161	Hepatitis B	2/8	173/7206	0.0145894942662
ko04217	Necroptosis	2/8	178/7206	0.0154044446997
ko05168	Herpes simplex infection	2/8	182/7206	0.0160706069613
ko05152	Tuberculosis	2/8	187/7206	0.01692090636
ko04060	Cytokine-cytokine receptor interaction	2/8	191/7206	0.0176151079547
ko05310	Asthma	1/8	17/7206	0.0187270812527
ko04062	Chemokine signaling pathway	2/8	201/7206	0.0194042583869
ko00592	alpha-Linolenic acid metabolism	1/8	19/7206	0.020909960907
ko00591	Linoleic acid metabolism	1/8	22/7206	0.0241763136784
ko05330	Allograft rejection	1/8	24/7206	0.0263485813954
ko05320	Autoimmune thyroid disease	1/8	29/7206	0.0317607495045
ko05340	Primary immunodeficiency	1/8	30/7206	0.0328400185588
ko04672	Intestinal immune network for IgA production	1/8	37/7206	0.0403654728365
ko00565	Ether lipid metabolism	1/8	42/7206	0.045709380268